铥纤维激光前列腺去核术:前瞻性多中心队列的初步经验以及术中和短期疗效分析

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY
J. Romero Otero , J. Justo Quintas , E. García Rojo , R. Sopeña Sutil , E. Peña Vallejo , F. Lista Mateos , G. Bozzini , D. Saenz Calzada , A. Rodríguez Antolín , B. García Gómez
{"title":"铥纤维激光前列腺去核术:前瞻性多中心队列的初步经验以及术中和短期疗效分析","authors":"J. Romero Otero ,&nbsp;J. Justo Quintas ,&nbsp;E. García Rojo ,&nbsp;R. Sopeña Sutil ,&nbsp;E. Peña Vallejo ,&nbsp;F. Lista Mateos ,&nbsp;G. Bozzini ,&nbsp;D. Saenz Calzada ,&nbsp;A. Rodríguez Antolín ,&nbsp;B. García Gómez","doi":"10.1016/j.acuro.2023.12.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.</p></div><div><h3>Material and methods</h3><p>All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.</p></div><div><h3>Results</h3><p>Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47<!--> <!-->g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3<!--> <!-->g, maximum urinary flow 13.2 vs 27.3<!--> <!-->ml/s, post-void residual volume 149 vs 7.8<!--> <!-->ml, prostatic specific antigen level 11.2 vs 1<!--> <!-->ng/ml, and International Prostate Symptom Score score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade<!--> <!-->≤<!--> <!-->2, according to the Clavien-Dindo classification.</p></div><div><h3>Discussion</h3><p>With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.</p></div><div><h3>Conclusions</h3><p>TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.</p></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"48 5","pages":"Pages 371-376"},"PeriodicalIF":1.2000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Enucleación prostática con láser de fibra de tulio: experiencia inicial y análisis de los resultados intraoperatorios y a corto plazo en una cohorte prospectiva multicéntrica\",\"authors\":\"J. Romero Otero ,&nbsp;J. Justo Quintas ,&nbsp;E. García Rojo ,&nbsp;R. Sopeña Sutil ,&nbsp;E. Peña Vallejo ,&nbsp;F. Lista Mateos ,&nbsp;G. Bozzini ,&nbsp;D. Saenz Calzada ,&nbsp;A. Rodríguez Antolín ,&nbsp;B. García Gómez\",\"doi\":\"10.1016/j.acuro.2023.12.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.</p></div><div><h3>Material and methods</h3><p>All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.</p></div><div><h3>Results</h3><p>Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47<!--> <!-->g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3<!--> <!-->g, maximum urinary flow 13.2 vs 27.3<!--> <!-->ml/s, post-void residual volume 149 vs 7.8<!--> <!-->ml, prostatic specific antigen level 11.2 vs 1<!--> <!-->ng/ml, and International Prostate Symptom Score score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade<!--> <!-->≤<!--> <!-->2, according to the Clavien-Dindo classification.</p></div><div><h3>Discussion</h3><p>With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.</p></div><div><h3>Conclusions</h3><p>TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.</p></div>\",\"PeriodicalId\":7145,\"journal\":{\"name\":\"Actas urologicas espanolas\",\"volume\":\"48 5\",\"pages\":\"Pages 371-376\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Actas urologicas espanolas\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210480624000019\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas urologicas espanolas","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210480624000019","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言钬激光前列腺去核术已迅速成为手术治疗良性前列腺增生的金标准,尽管铥光纤激光(TFL)也被认为是前列腺去核术的一种有效而安全的替代方法。本研究旨在描述我们使用铥光纤激光器进行前列腺内窥镜去核术的初步经验。材料和方法在 3 个中心,所有拟接受铥光纤激光器前列腺去核术的患者,无论其前列腺体积、导管状态和症状严重程度如何,均纳入分析范围。收集了术前特征、术中时间和 3 个月功能随访变量以及并发症。去核和去骨效率分别为2.04克/分钟和7.47克/分钟。住院时间中位数为一天。手术前和手术后三个月的功能数据比较如下:前列腺平均体积 88.9 vs 21.3 g,最大尿流 13.2 vs 27.3 ml/s,排尿后残余体积 149 vs 7.8 ml,前列腺特异抗原水平 11.2 vs 1 ng/ml,国际前列腺症状评分 20.75 vs 3.96。根据 Clavien-Dindo 分类法,56 例患者中有 14 例(25%)出现了≤2 级并发症。讨论自 2021 年描述第一例病例以来,随着其他泌尿科适应症的证据越来越多,关于 TFL 是否适用于前列腺摘除术的证据也越来越多。我们的结果似乎证实了之前的成功经验,只要我们获得良好的术中和短期随访功能结果。结论TFL是一种用于前列腺去核术的新型技术,具有良好的术中和短期随访功能效果,其安全性与已广泛应用于该适应症的技术相似。有必要进行更长时间的随访研究,并与其他技术进行比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Enucleación prostática con láser de fibra de tulio: experiencia inicial y análisis de los resultados intraoperatorios y a corto plazo en una cohorte prospectiva multicéntrica

Introduction

Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.

Material and methods

All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.

Results

Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47 g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3 g, maximum urinary flow 13.2 vs 27.3 ml/s, post-void residual volume 149 vs 7.8 ml, prostatic specific antigen level 11.2 vs 1 ng/ml, and International Prostate Symptom Score score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade  2, according to the Clavien-Dindo classification.

Discussion

With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.

Conclusions

TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Actas urologicas espanolas
Actas urologicas espanolas UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
98
审稿时长
46 days
期刊介绍: Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology. Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信